Searched for
GRANULES PHARMACEUTICALS
Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...- NCB busts illegal Captagon factory in Uttarakhand, owner arrested after Operation RAGEPILLThe Narcotics Control Bureau (NCB) arrested a factory owner in Uttarakhand following a raid that uncovered a Captagon manufacturing operati...
- Ahead of Market: 10 things that will decide stock market action on TuesdayThe Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- Drugmaker Granules to tighten oversight after US FDA warning, executive saysThe company, which is globally one of the largest paracetamol makers and a major player in the active pharmaceutical ingredients market, de...
- Indian drugmaker Granules to tighten oversight after US FDA warning, exec saysAmid growing scrutiny from the U.S. FDA over documentation practices and contamination issues, Granules India is reinforcing its manufactur...
- Granules India gets USFDA nod for generic drugGranules Pharmaceuticals, Inc. secured USFDA approval for generic Lisdexamfetamine Dimesylate chewable tablets. The tablets treat ADHD in c...
- Granules India gets USFDA nod for generic Glycopyrrolate oral solutionGranules Pharmaceuticals Inc, a subsidiary of Granules India, has received approval from the USFDA for a generic Glycopyrrolate oral soluti...
- Granules gets USFDA's nod for Amphetamine capsulesAmphetamine is bioequivalent to the reference listed drug product (RLD), Adderall XR extended-release capsules of Takeda Pharmaceuticals. T...
- USFDA issues 3 minor observations to Granules India arm in pre-approval inspectionCommenting on the audit, GPI Executive Director Priyanka Chigurupati said, "We are glad to have completed yet another audit with minor obse...
- Granules India gets USFDA nod for generic Prazosin Hydrochloride capsulesThe US Food & Drug Administration (USFDA) granted approval to the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals...
- Granules India gets Health Canada nod to market arthritis tabletsThe drug will be manufactured at the company's manufacturing facility located in Gagillapur, Hyderabad, the filing said.
- USFDA issues two observations after inspection of Granules India's Chantilly facility in US"We will be responding to the two observations within the stipulated time period," Granules Pharmaceuticals Executive Director Priyanka Chi...
- Granules arm gets American health regulator's nod for Potassium Chloride Oral SolutionIn a BSE filing, Granules said the US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed b...
- Granules India rises 3% on USFDA nod to insomnia drugThe company now has a total of 29 ANDA approvals from USFDA (27 final approvals and 2 tentative approvals), Granules India said.
- Granules India gets USFDA nod for overactive bladder treatment capsule"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wh...
- Granules' US unit gets two USFDA observationsAs per the USFDA, a Form 483, is issued to a firm's management at the conclusion of an inspection when investigator has observed any condit...
- Granules' arm completes audit with USFDAGranules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company completed its first audit from December 4-8, 2017 by the USF...
- Granules India Q1 net profit rises by 37% to Rs 39 croreOperating margin improved by 96 basis points to 20.8 per cent from 19.9 per cent and net profit margin by 249 basis points to 11.3 per cent...
- Granules to acquire 12.5 per cent stake in USpharmaUSpharma is a development-stage pharmaceutical company specialising in research, development and manufacture of high entry-barrier generic ...
Load More
